FDA approves first generic EpiPen competitor Source: Cox Media Group


Today's approval of the first generic version of the most-widely prescribed epinephrine auto-injector in the U.S. is part of our commitment to making lower cost, safe, and effective generic alternatives available to patients. https://t.co/D2xkAYFKKQ The new drug, from Teva Pharmaceuticals USA, can now automatically be substituted at the pharmacy counter for EpiPen and EpiPen Jr. prescriptions, The Washington Post reported .



from Biotech News